Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion type Assertion NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_head.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion description "[Pharmacogenetics of tardive dyskinesia and dopamine D3 (DRD3), serotonin 2A (HTR2A), and 2C (HTR2C) receptors has been examined in various populations, but not in Russians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_provenance.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion evidence source_evidence_literature NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_provenance.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion SIO_000772 19439249 NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_provenance.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion wasDerivedFrom befree-20150227 NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_provenance.
- NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_assertion wasGeneratedBy ECO_0000203 NP471602.RAacZhgU3v9WwUV9J3RTeK4BAsNUChO8hM-DCaGmiVvEA130_provenance.